Durham drug developer Chimerix raised more than $102 million Wednesday as the 46-employee company offered its stock to Wall Street in the Triangle's second initial public offering this year.
http://www.newsobserver.com/2013/04/11/2818061/durham-drug-developer-chimerix.html#storylink=rss
http://www.newsobserver.com/2013/04/11/2818061/durham-drug-developer-chimerix.html#storylink=rss
No comments:
Post a Comment